Takahara, I., Akazawa, Y., Tabuchi, M., Matsuda, K., Miyaaki, H., Kido, Y., . . . Nakao, K. (2017). Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice. PLoS One.
Chicago-tyylinen lähdeviittausTakahara, Ikuko, et al. "Toyocamycin Attenuates Free Fatty Acid-induced Hepatic Steatosis and Apoptosis in Cultured Hepatocytes and Ameliorates Nonalcoholic Fatty Liver Disease in Mice." PLoS One 2017.
MLA-viiteTakahara, Ikuko, et al. "Toyocamycin Attenuates Free Fatty Acid-induced Hepatic Steatosis and Apoptosis in Cultured Hepatocytes and Ameliorates Nonalcoholic Fatty Liver Disease in Mice." PLoS One 2017.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.